Cargando…

Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation

Nosocomial acute-on-chronic liver failure (nACLF) develops in at least 10% of patients with cirrhosis hospitalized for acute decompensation (AD), greatly worsening their prognosis. In this prospective observational study, we aimed to identify rapidly obtainable predictors at admission, which allow f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaccherini, Giacomo, Baldassarre, Maurizio, Bartoletti, Michele, Tufoni, Manuel, Berardi, Sonia, Tamè, Mariarosa, Napoli, Lucia, Siniscalchi, Antonio, Fabbri, Angela, Marconi, Lorenzo, Antognoli, Agnese, Iannone, Giulia, Domenicali, Marco, Viale, Pierluigi, Trevisani, Franco, Bernardi, Mauro, Caraceni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001573/
https://www.ncbi.nlm.nih.gov/pubmed/32039378
http://dx.doi.org/10.1016/j.jhepr.2019.07.005
_version_ 1783494269662658560
author Zaccherini, Giacomo
Baldassarre, Maurizio
Bartoletti, Michele
Tufoni, Manuel
Berardi, Sonia
Tamè, Mariarosa
Napoli, Lucia
Siniscalchi, Antonio
Fabbri, Angela
Marconi, Lorenzo
Antognoli, Agnese
Iannone, Giulia
Domenicali, Marco
Viale, Pierluigi
Trevisani, Franco
Bernardi, Mauro
Caraceni, Paolo
author_facet Zaccherini, Giacomo
Baldassarre, Maurizio
Bartoletti, Michele
Tufoni, Manuel
Berardi, Sonia
Tamè, Mariarosa
Napoli, Lucia
Siniscalchi, Antonio
Fabbri, Angela
Marconi, Lorenzo
Antognoli, Agnese
Iannone, Giulia
Domenicali, Marco
Viale, Pierluigi
Trevisani, Franco
Bernardi, Mauro
Caraceni, Paolo
author_sort Zaccherini, Giacomo
collection PubMed
description Nosocomial acute-on-chronic liver failure (nACLF) develops in at least 10% of patients with cirrhosis hospitalized for acute decompensation (AD), greatly worsening their prognosis. In this prospective observational study, we aimed to identify rapidly obtainable predictors at admission, which allow for the early recognition and stratification of patients at risk of nACLF. METHODS: A total of 516 consecutive patients hospitalized for AD of cirrhosis were screened: those who did not present ACLF at admission (410) were enrolled and surveilled for the development of nACLF. RESULTS: Fifty-nine (14%) patients developed nALCF after a median of 7 (IQR 4–18) days. At admission, they presented a more severe disease and higher degrees of systemic inflammation and anemia than those (351; 86%) who remained free from nACLF. Competing risk multivariable regression analysis showed that baseline MELD score (sub-distribution hazard ratio [sHR] 1.15; 95% CI 1.10–1.21; p ≪0.001), hemoglobin level (sHR 0.81; 95% CI 0.68–0.96; p = 0.018), and leukocyte count (sHR 1.11; 95% CI 1.06–1.16; p ≪0.001) independently predicted nACLF. Their optimal cut-off points, determined by receiver-operating characteristic curve analysis, were: 13 points for MELD score, 9.8 g/dl for hemoglobin, and 5.6x10(9)/L for leukocyte count. These thresholds were used to stratify patients according to the cumulative incidence of nACLF, being 0, 6, 21 and 59% in the presence of 0, 1, 2 or 3 risk factors (p ≪0.001). Nosocomial bacterial infections only increased the probability of developing nACLF in patients with at least 1 risk factor, rising from 3% to 29%, 16% to 50% and 52% to 83% in patients with 1, 2 or 3 risk factors, respectively. CONCLUSIONS: Easily available laboratory parameters, related to disease severity, systemic inflammation, and anemia, can be used to identify, at admission, hospitalized patients with AD at increased risk of developing nACLF. LAY SUMMARY: More than 10% of patients with cirrhosis hospitalized because of an acute decompensation develop acute-on-chronic liver failure, which is associated with high short-term mortality, during their hospital stay. We found that the combination of 3 easily obtainable variables (model for end-stage liver disease score, leukocyte count and hemoglobin level) help to identify and stratify patients according to their risk of developing nosocomial acute-on-chronic liver failure, from nil to 59%. Moreover, if a nosocomial bacterial infection occurs, such an incidence proportionally increases from nil to 83%. This simple approach helps to identify patients at risk of developing nosocomial acute-on-chronic liver failure at admission to hospital, enabling clinicians to put in place preventive measures.
format Online
Article
Text
id pubmed-7001573
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70015732020-02-07 Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation Zaccherini, Giacomo Baldassarre, Maurizio Bartoletti, Michele Tufoni, Manuel Berardi, Sonia Tamè, Mariarosa Napoli, Lucia Siniscalchi, Antonio Fabbri, Angela Marconi, Lorenzo Antognoli, Agnese Iannone, Giulia Domenicali, Marco Viale, Pierluigi Trevisani, Franco Bernardi, Mauro Caraceni, Paolo JHEP Rep Research Article Nosocomial acute-on-chronic liver failure (nACLF) develops in at least 10% of patients with cirrhosis hospitalized for acute decompensation (AD), greatly worsening their prognosis. In this prospective observational study, we aimed to identify rapidly obtainable predictors at admission, which allow for the early recognition and stratification of patients at risk of nACLF. METHODS: A total of 516 consecutive patients hospitalized for AD of cirrhosis were screened: those who did not present ACLF at admission (410) were enrolled and surveilled for the development of nACLF. RESULTS: Fifty-nine (14%) patients developed nALCF after a median of 7 (IQR 4–18) days. At admission, they presented a more severe disease and higher degrees of systemic inflammation and anemia than those (351; 86%) who remained free from nACLF. Competing risk multivariable regression analysis showed that baseline MELD score (sub-distribution hazard ratio [sHR] 1.15; 95% CI 1.10–1.21; p ≪0.001), hemoglobin level (sHR 0.81; 95% CI 0.68–0.96; p = 0.018), and leukocyte count (sHR 1.11; 95% CI 1.06–1.16; p ≪0.001) independently predicted nACLF. Their optimal cut-off points, determined by receiver-operating characteristic curve analysis, were: 13 points for MELD score, 9.8 g/dl for hemoglobin, and 5.6x10(9)/L for leukocyte count. These thresholds were used to stratify patients according to the cumulative incidence of nACLF, being 0, 6, 21 and 59% in the presence of 0, 1, 2 or 3 risk factors (p ≪0.001). Nosocomial bacterial infections only increased the probability of developing nACLF in patients with at least 1 risk factor, rising from 3% to 29%, 16% to 50% and 52% to 83% in patients with 1, 2 or 3 risk factors, respectively. CONCLUSIONS: Easily available laboratory parameters, related to disease severity, systemic inflammation, and anemia, can be used to identify, at admission, hospitalized patients with AD at increased risk of developing nACLF. LAY SUMMARY: More than 10% of patients with cirrhosis hospitalized because of an acute decompensation develop acute-on-chronic liver failure, which is associated with high short-term mortality, during their hospital stay. We found that the combination of 3 easily obtainable variables (model for end-stage liver disease score, leukocyte count and hemoglobin level) help to identify and stratify patients according to their risk of developing nosocomial acute-on-chronic liver failure, from nil to 59%. Moreover, if a nosocomial bacterial infection occurs, such an incidence proportionally increases from nil to 83%. This simple approach helps to identify patients at risk of developing nosocomial acute-on-chronic liver failure at admission to hospital, enabling clinicians to put in place preventive measures. Elsevier 2019-08-01 /pmc/articles/PMC7001573/ /pubmed/32039378 http://dx.doi.org/10.1016/j.jhepr.2019.07.005 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Zaccherini, Giacomo
Baldassarre, Maurizio
Bartoletti, Michele
Tufoni, Manuel
Berardi, Sonia
Tamè, Mariarosa
Napoli, Lucia
Siniscalchi, Antonio
Fabbri, Angela
Marconi, Lorenzo
Antognoli, Agnese
Iannone, Giulia
Domenicali, Marco
Viale, Pierluigi
Trevisani, Franco
Bernardi, Mauro
Caraceni, Paolo
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
title Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
title_full Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
title_fullStr Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
title_full_unstemmed Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
title_short Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
title_sort prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001573/
https://www.ncbi.nlm.nih.gov/pubmed/32039378
http://dx.doi.org/10.1016/j.jhepr.2019.07.005
work_keys_str_mv AT zaccherinigiacomo predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT baldassarremaurizio predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT bartolettimichele predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT tufonimanuel predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT berardisonia predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT tamemariarosa predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT napolilucia predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT siniscalchiantonio predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT fabbriangela predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT marconilorenzo predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT antognoliagnese predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT iannonegiulia predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT domenicalimarco predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT vialepierluigi predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT trevisanifranco predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT bernardimauro predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation
AT caracenipaolo predictionofnosocomialacuteonchronicliverfailureinpatientswithcirrhosisadmittedtohospitalwithacutedecompensation